PRSS35 Inhibitors

Chemical inhibitors of PRSS35 can impede the protein's function through various mechanisms, all of which involve the targeted disruption of its proteolytic activity. AEBSF is one such inhibitor, which functions by covalently modifying the hydroxyl group of the serine residue in the active site of PRSS35, thereby obstructing its enzymatic action. The chemical, 4-(2-Aminoethyl) benzenesulfonyl fluoride hydrochloride, operates in a similar capacity, directly engaging with the serine residue of PRSS35 to prevent the cleavage of peptide bonds that the protease would otherwise catalyze. Gabexate mesilate and Nafamostat mesilate act along the same lines, providing a blockade to the active site of PRSS35 and precluding its normal protease function. The intervention of these chemicals ensures that the substrate-specific cleavage typically executed by PRSS35 is halted.

Further inhibition is achieved with chemicals such as Camostat mesilate, which binds to PRSS35 and inhibits its activity by masking the enzyme's active site, preventing interaction with its substrates. Sivelestat and Alvelestat, while initially developed to inhibit neutrophil elastase, possess the ability to inhibit serine proteases broadly, including PRSS35, by binding to the active site of the enzyme. Z-FA-FMK, a peptide-based inhibitor, interacts with PRSS35 in a similar fashion, preventing the hydrolysis of substrate proteins. Ulinastatin offers inhibition by binding to PRSS35 and other serine proteases, thereby suppressing the enzyme's activity. Aprotinin, a broad-spectrum protease inhibitor, can also inhibit PRSS35 by forming reversible stoichiometric complexes with serine proteases. Lastly, Leupeptin, which inhibits both serine and cysteine proteases, provides inhibition of PRSS35 through the formation of a stable complex with the active site of the enzyme, effectively neutralizing its proteolytic function. Each of these chemicals acts to directly inhibit the activity of PRSS35, ensuring that the protein's role in catalyzing the breakdown of specific peptide bonds is prevented.